Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) [Phase 2]

View source ↗

Summary

Pfizer is conducting a Phase 2 study called BRANCH-HF to evaluate PF-07328948 in adults with heart failure. The trial status is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• PF-07328948

Snippet

Sponsor: Pfizer | Conditions: Heart Failure | Phase 2 | Status: RECRUITING